AI assistant
Sending…
ABBOTT LABORATORIES — Director's Dealing 2019
Feb 1, 2019
29777_dirs_2019-02-01_922f4783-d132-4a47-8c07-a1a716353931.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2019-01-31
Reporting Person: Stratton John G (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-01-31 | Common shares without par value | P | 613 | $72.31 | Acquired | 3558 | Direct |
| 2019-01-31 | Common shares without par value | P | 842 | $72.32 | Acquired | 4400 | Direct |
| 2019-01-31 | Common shares without par value | P | 1800 | $72.33 | Acquired | 6200 | Direct |
| 2019-01-31 | Common shares without par value | P | 100 | $72.305 | Acquired | 6300 | Direct |
| 2019-01-31 | Common shares without par value | P | 100 | $72.315 | Acquired | 6400 | Direct |
More from ABBOTT LABORATORIES
Regulatory Filings
2026
Jul 16
Annual Report
2026
Jun 18
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Board/Management Information
2026
Apr 27
Regulatory Filings
2026
Apr 24
Legal Proceedings Report
2026
Apr 17
Call Transcript
2026
Apr 16
Earnings Release
2026
Apr 16